Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 214-317-9 | CAS number: 1120-71-4
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
Waiving of the fertility study due to classification regarding carcinogenicity (Carc. 1B, H350) and mutagenicity (Cat.2, H341) according to REACH legal text Annex VIII: "Standard information requirements for substances manufactured or imported in quantities of 10 tonnes or more", Column 2.
Effect on fertility: via oral route
- Endpoint conclusion:
- no study available
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
1,3-propanesultone has been found to be carcinogenic in rats and mice by any of several routes of administration (i.e. oral, dermal, subcutaneous, i.v., transplacental). Based on the available data regarding carcinogenicity 1,3-propanesultone is subject to classification and labelling: Carc. 1B, H350 according to Regulation 1272/2008/EC. Additionally, a high potential for genetic toxicity of the test item was indicated in in vitro and in vivo test systems (e.g. Ames test, chromosomal aberration test, micronucleus test) - see chapter Genetic toxicity - and therefore the substance is subject for classification and labelling according to Regulation 1272/2008/EC (Cat. 2, H341) regarding mutagenicity. According to the REACH legal text Annex VIII: "Standard information requirements for substances manufactured or imported in quantities of 10 tonnes or more", studies on the toxicity of reproduction do not need to be conducted if the substance is known to be a genotoxic carcinogen and / or a germ cell mutagen and appropriate risk management measures are implemented, as is the case for 1,3-propanesultone. Therefore, a study on fertility does not need to be performed.
Effects on developmental toxicity
Description of key information
Waiving of the developmental toxicity study due to classification regarding carcinogenicity (Carc. 1B, H350) and mutagenicity (Cat.2, H341) according to REACH legal text Annex VIII: "Standard information requirements for substances manufactured or imported in quantities of 10 tonnes or more", Column 2.
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Additional information
1,3-propanesultone has been found to be carcinogenic in rats and mice by any of several routes of administration (i.e. oral, dermal, subcutaneous, i.v., transplacental) - see chapter Carcinogenicity. Based on the available data regarding carcinogenicity 1,3-propanesultone is subject to classification and labelling: Carc. 1B, H350 according to Regulation 1272/2008/EC. Additionally, a high potential for genetic toxicity of the test item was indicated in in vitro and in vivo test systems (e.g. Ames test, chromosomal aberration test, micronucleus test) - see chapter Genetic toxicity - and therefore the substance is subject for classification and labelling according to Regulation 1272/2008/EC (Cat. 2, H341) regarding mutagenicity. According to the REACH legal text Annex VIII: "Standard information requirements for substances manufactured or imported in quantities of 10 tonnes or more", studies on the toxicity of reproduction do not need to be conducted if the substance is known to be a genotoxic carcinogen and / or a germ cell mutagen and appropriate risk management measures are implemented, as is the case for 1,3-propanesultone. Therefore, a study on developmental toxicity does not need to be performed.
Justification for classification or non-classification
No data available regarding reproductive toxicity.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
